Manufacturers and the most important players in the market for hyaluronic acid products have been increasing their concentration towards introducing new implants with custom-made features for the minimally invasive surgery. Apart from this, they are working towards reduction of high costs, thereby raising their position across the globe. Entering into collaborations is also a strategic move made by the manufacturers and the most important players in the market for hyaluronic acid products. Innovations, combination products as well as next-gen injections are some of the major factors contributing towards the growth of market for hyaluronic acid products.
A research firm has taken up a comprehensive analysis on the report named market for hyaluronic acid products, thereby disclosing valuable figures and facts related to the global market. Report indicates that market for hyaluronic acid products is anticipated to develop at 7.8% CAGR during 2017-2027, in order to touch an estimation of nearly US$ 5Bn by the end of 2027.
Most important players operating in the global market for hyaluronic acid products are inclusive of Allergan plc, Fidia Farmaceutici S.p.A., Smith & Nephew, Galderma SA (Nestle Skin Health Company), Anika Therapeutics Inc., Seikagaku Corporation and Salix Pharmaceuticals Ltd. (Sub. Valeant). Manufacturers and the most important players have been concentrating on innovating and introducing new products that would cater to their business expansion plans as well as increasing customer-base worldwide.
Allergan plc Develops New Artificial Tear Formulation
Manufacturers and the most important players can take account of the point that Allergan plc has been launching an innovative OTC (over-the-counter) artificial tear formulation, which is named as REFRESH® REPAIR Lubricant Eye Drops. These artificial tear drops have been formulated with the combination of osmoprotectants, hyaluronic acid and carboxymethylcellulose. The company has added REFRESH® REPAIR as the latest inclusion in its REFRESH® portfolio. The newly developed artificial tears have been introduced for the purpose of protecting and repairing the eyes from dangerous effects of the dry eye as well as improves clarity of the vision.
Another focal point is that this new REFRESH® REPAIR Lubricant Eye Drops helps the doctors in tailoring therapy depending on the requirements of the patients. Customers can take note of the matter that this new REFRESH® REPAIR Lubricant Eye Drops is highly beneficial as it offers unique osmoprotective benefits and improved comfort to patients suffering from dry eye, which helps in safeguarding health of the epithelial cells, hostile to hyperosmotic stress.
Insights on REFRESH® REPAIR Lubricant Eye Drops
Customers can note the important point that several clinical studies have showed improvement symptoms and signs of dry eye as well as improvement in visual performance in the dry eye patients. Most of all, there is considerably low cases of the side effects occurring due to this product such as stickiness and blur during blinking. Dry eye science is turning out to be supremely sophisticated since the last decade and effective treatments for healthy ocular surface is turning out to be a major want across the globe, for which, recently Allergan plc developed REFRESH® REPAIR Lubricant Eye Drops.
A sample of this report is available upon request @ https://www.futuremarketinsights.com/reports/sample/rep-gb-486
